By these methods, the prepared diagnostic sera for botulinum toxin type A, B, C, D, E, F can neutralize more than 10000 LD_(50)/ml of same type botulinum toxin, on the other hand, they neutralize less than 5 LD_(50)/ml of other types of botulinum toxin or tetanus toxin.
Botulinum toxin type A (BoNTA) has been suggested as an effective anti-spastic drug.
NT 201 is a new development of Botulinum Toxin Type A free of complexing proteins.
Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
Purpose: This randomized controlled trial was performed to compare the novel botulinum toxin type A free of complexing proteins (NT 201) with the marketed preparation BOTOX° regarding efficacy and tolerability.
Efficacy and tolerability of a botulinum toxin type A free of complexing proteins (NT 201) compared with commercially available